Novanta (LTS:0VAG) Cyclically Adjusted Revenue per Share: $24.28 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0VAG Novanta Inc LTS:0VAG
93 GF Score
Price $169.63
GF Value $154.46
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Novanta Cyclically Adjusted Revenue per Share?

Novanta LTS:0VAG +0.93% 93 Cyclically Adjusted Revenue per Share is $24.28 as of Jun. 2026. GuruFocus rates LTS:0VAG with a GF Score™ of 93/100 and a GF Value™ of $154.46 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Novanta's adjusted revenue per share for the three months ended in Jun. 2026 was $6.457. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $24.28 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novanta's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Novanta was 13.40% per year. The lowest was -8.00% per year. And the median was -3.00% per year.

As of today (2026-08-09), Novanta's current stock price is $169.63. Novanta's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $24.28. Novanta's Cyclically Adjusted PS Ratio of today is 6.99.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novanta was 12.47. The lowest was 1.10. And the median was 6.80.


Novanta  (LTS:0VAG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Novanta's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=169.63/24.28
=6.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Novanta was 12.47. The lowest was 1.10. And the median was 6.80.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Novanta Cyclically Adjusted Revenue per Share Related Terms


Novanta Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Novanta's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novanta Cyclically Adjusted Revenue per Share Chart

Novanta Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.70 17.95 19.57 21.26 22.85

Novanta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.31 22.62 22.85 22.87 24.28

LTS:0VAG vs VNT, ITRI, BMI: Cyclically Adjusted Revenue per Share Comparison

For the Scientific & Technical Instruments subindustry, Novanta's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novanta Cyclically Adjusted PS Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Novanta's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Novanta's Cyclically Adjusted PS Ratio falls into.


LTS:0VAG
93GF Score
Novanta Inc LTS:0VAG
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novanta Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novanta's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.457/333.9520*333.9520
=6.457

Current CPI (Jun. 2026) = 333.9520.

Novanta Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.801 241.428 3.874
201612 2.826 241.432 3.909
201703 3.102 243.801 4.249
201706 3.358 244.955 4.578
201709 4.200 246.819 5.683
201712 4.148 246.524 5.619
201803 4.148 249.554 5.551
201806 4.240 251.989 5.619
201809 4.531 252.439 5.994
201812 4.401 251.233 5.850
201903 4.431 254.202 5.821
201906 4.370 256.143 5.697
201909 4.330 256.759 5.632
201912 4.484 256.974 5.827
202003 4.372 258.115 5.657
202006 4.068 257.797 5.270
202009 4.005 260.280 5.139
202012 4.121 260.474 5.284
202103 4.543 264.877 5.728
202106 4.684 271.696 5.757
202109 4.969 274.310 6.049
202112 5.556 278.802 6.655
202203 5.707 287.504 6.629
202206 5.993 296.311 6.754
202209 6.206 296.808 6.983
202212 6.067 296.797 6.827
202303 6.087 301.836 6.735
202306 6.368 305.109 6.970
202309 6.146 307.789 6.668
202312 5.868 306.746 6.388
202403 6.392 312.332 6.834
202406 6.535 314.175 6.946
202409 6.765 315.301 7.165
202412 6.586 315.605 6.969
202503 6.459 319.799 6.745
202506 6.682 322.561 6.918
202509 6.877 324.800 7.071
202512 6.700 324.054 6.905
202603 6.261 330.213 6.332
202606 6.457 333.952 6.457

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $24.28 mean?
Novanta (LTS:0VAG) has a Cyclically Adjusted Revenue per Share of $24.28 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novanta and its competitors.
Is Novanta's Cyclically Adjusted Revenue per Share too high?
Novanta's current Cyclically Adjusted Revenue per Share is $24.28. Overall, Novanta has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novanta's Cyclically Adjusted Revenue per Share compare to VNT and ITRI?
Novanta's Cyclically Adjusted Revenue per Share of $24.28 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Hardware company?
A good Cyclically Adjusted Revenue per Share depends on the Hardware industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novanta and its competitors. Novanta's current Cyclically Adjusted Revenue per Share is $24.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novanta stock overvalued right now?
Based on GuruFocus' analysis, Novanta (LTS:0VAG) is currently considered Fairly Valued. The stock's GF Value™ is $154.46, compared to a current price of $169.63 — trading 9.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $24.28. Novanta's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Novanta (LTS:0VAG), the current Cyclically Adjusted Revenue per Share is $24.28 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novanta (LTS:0VAG) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be overvalued. The current stock price of $169.63 is trading 9.8% above its estimated GF Value™ of $154.46. GuruFocus considers Novanta to be Fairly Valued.

Key valuation signals for LTS:0VAG:

  • Cyclically Adjusted Revenue per Share: $24.28
  • GF Value™: $154.46 vs. price of $169.63 (9.8% above fair value)
  • GF Score™: 93/100 with 7 warning signs

No single metric tells the full story. See the LTS:0VAG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novanta Business Description

Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
93GF Score

Get the complete analysis for LTS:0VAG

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$169.63
Price
$154.46
GF Value